Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia: Challenges, Characteristics, and Analysis of Clinical Experience

Background & Aims. Paroxysmal nocturnal hemoglobinuria (PNH) is a disease caused by an acquired clonal disorder of hematopoietic stem cells with clone cell membrane hypersensitivity to the complement. PNH can exist as an independent disease and can also be associated with other pathological conditio...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Elena Romanovna Shilova, T. V. Glazanova, Zh. V. Chubukina, O. E. Rozanova, M. N. Zenina, A. V. Seltser, V. I. Rugal, V. A. Balashova, V. A. Kobilyanskaya, I. I. Krobinets, V. Yu. Udal’eva, I. I. Zotova, L. V. Stelmashenko, N. A. Romanenko, T. B. Zamotina, I. V. Khorsheva, S. V. Voloshin
Aineistotyyppi:	Artigo
Kieli:	Russo
Julkaistu:	Practical Medicine Publishing House 2019-07-01
Sarja:	Клиническая онкогематология
Aiheet:	aplastic anemia paroxysmal nocturnal hemoglobinuria pnh phenotype pnh clone targeted therapy c3-mediated hemolysis
Linkit:	https://bloodjournal.ru/index.php/coh/article/view/327
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!